The envelop proteins of HERVs, such as syncytin-1 and HERV-K (HML-2) ENV, have been reported to contribute to tumorigenesis by inducing cell–cell fusion in melanoma [106], endometrial carcinoma [130], and breast cancer [121]. Here, ERVW-1 is linked to breast cancer.